PD-L1 expression on malignant cells is no prerequisite for checkpoint therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PD-L1 expression on malignant cells is no prerequisite for checkpoint therapy

Published:2017-02-21 Issue:4 Volume:6 Page:e1294299
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Kleinovink Jan Willem¹,Marijt Koen A.²,Schoonderwoerd Mark J. A.³,van Hall Thorbald²,Ossendorp Ferry¹,Fransen Marieke F.¹

Affiliation:

1. Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, the Netherlands

2. Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands

3. Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, the Netherlands

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://tandfonline.com/doi/pdf/10.1080/2162402X.2017.1294299

Reference22 articles.

1. Coinhibitory Pathways in Immunotherapy for Cancer

2. PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations

3. Immune Checkpoint Blockade in Cancer Therapy

4. Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial

5. Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial

Cited by 119 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PD-L1 and PD-1 in immune regulation and their implications in blood cancers;Advances in Cancer Biology - Metastasis;2024-10

2. Interferon-γ driven differentiation of monocytes into PD-L1⁺and MHC II⁺macrophages and the frequency of Tim-3⁺tumor-reactive CD8⁺T cells within the tumor microenvironment predict a positive response to anti-PD-1-based therapy in tumor-bearing mice;2024-08-04

3. From foes to friends: rethinking the role of lymph nodes in prostate cancer;Nature Reviews Urology;2024-08-02

4. MHC-I and PD-L1 Expression is Associated with Decreased Tumor Outgrowth and is Radiotherapy-inducible in the Murine Head and Neck Squamous Cell Carcinoma Model MOC1;Molecular Imaging and Biology;2024-07-15

5. MB2033, an anti-PD-L1 × IL-2 variant fusion protein, demonstrates robust anti-tumor efficacy with minimal peripheral toxicity;Cancer Immunology, Immunotherapy;2024-06-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3